Search

Search Constraints

You searched for: Author/Creator Vernero, M.

Search Results

1. OC.02.1 SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD). (May 2022)

3. OC.11.6 STIGMATISATION AND RESILIENCE IN INFLAMMATORY BOWEL DISEASE: A SINGLE-CENTRE, LONGITUDINAL STUDY. (1st October 2020)

4. OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY. (March 2023)

5. OC.14.7: The Role of Anti-IFI16 Antibodies in the Management of Inflammatory Bowel Diseases (IBD). (15th March 2017)

6. OC.16.3 GASTROINTESTINAL BEHÇET DISEASE: CLINICAL, ENDOSCOPIC, HISTOLOGICAL FEATURES AND ASSOCIATION WITH COELIAC DISEASE IN A TERTIARY REFERRAL CENTRE. (March 2023)

8. PC.01.4 REDUCED IMMUNE RESPONSE INDUCED BY TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IG-IBD STUDY. (May 2022)

10. T.05.10 CLINICAL HETEROGENEITY OF ADULT COELIAC DISEASE ACCORDING TO THE AGE AT ONSET: AN ITALIAN MULTICENTRIC STUDY. (March 2023)